Prognostic prediction and treatment strategy in hepatocellular carcinoma
- 1 March 2002
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 35 (3), 519-524
- https://doi.org/10.1053/jhep.2002.32089
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Reply:Hepatology, 2001
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJournal of Hepatology, 2001
- Radiofrequency ablation in the treatment of hepatocellular carcinoma - a clinical viewpointJournal of Hepatology, 2000
- Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survivalHepatology, 2000
- Right lobe living donor liver transplantation: A reviewLiver Transplantation, 2000
- A new prognostic classification for predicting survival in patients with hepatocellular carcinomaJournal of Hepatology, 1999
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patientsGastroenterology, 1995
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990